Tag | Content |
---|
EnhancerAtlas ID | HS165-14379 |
Organism | Homo sapiens |
Tissue/cell | Ramos |
Coordinate | chr7:92410200-92411840 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Hnf4a | MA0114.3 | chr7:92410941-92410957 | ATTAAACTTTGACCCA | - | 6.13 | Klf1 | MA0493.1 | chr7:92411671-92411682 | AGCCACACCCT | + | 6.02 | POU4F2 | MA0683.1 | chr7:92411263-92411279 | CTCATTAAATATGGAC | - | 6.43 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_13316 | chr7:92411244-92414103 | CD34_Primary_RO01536 | SE_25329 | chr7:92410116-92414144 | DND41 | SE_37463 | chr7:92409688-92411594 | HSMMtube | SE_49831 | chr7:92410992-92416011 | RPMI-8402 | SE_66249 | chr7:92411492-92413089 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH07I092780 | chr7 | 92409615 | 92411479 | GH07I092782 | chr7 | 92411493 | 92414142 |
|
Enhancer Sequence | CTTTCTAAAA CCTTTTTTTA AAAATTTTTG CTAATCTGTA ACCTGACAAA AATACCATTT 60 CAAGAATTAC ATGACAGCAG TTCCATAAGA AAAATGTAAT CACAATGTAT TGAATATGAA 120 CAAAATATCT CAGATGACTT TTAAAGGAAA GGAAAATTAC CATTAAATAT TTATCCATTA 180 GAGCTTAGCA TAATGTGATC CAAGTGAATG TTCAAAAAGT CAAAGTGCAA ACTGGTTATT 240 GGCATTAACT AAGGCTATGC CTTCAGTTTA GCTGTGCAAA ATGCAATCCA AAAAAGGCAG 300 ATAGGTCGTT ATCATTTCAC AATTAAGTTG GCCAAGCCCC TAACTCTCCC ACAAAGTAAG 360 TTCTCTTGCT GTCTCTATTG TCCTGACCCG CCAGCTGCAG GGCAGAGAAC AAGGCTTGCA 420 GTCCAGCACA GCACTCAGTT TTCCAGCTGT CCTAGTGATG TAATTATCTA ATAACAAAAT 480 ATCTCTCTGA ATTAACTCTG CATCCTACCC ATTGTAATTC TTAATGACTA CTTCCTGTTC 540 ATGTTCTCAA TTTAACTTGC TCTTCTGGAA CTATTGCATA GGCAAGTTGC CTTCATCTAA 600 TGGATGGGAT TACATCCAAT AGGTTTGGGA TTTCCAAAGA TTACAATTTA CAAAGGTCTC 660 CCAAACAACA TGCTTTGTAA ACACAAGCCC TGCCTTTCTA TTGTGGTTAC AATAAAAGGG 720 AAATCTGTCT TATTTGCTGT GATTAAACTT TGACCCATTC ACAGGAAGTT CTATGAGGAT 780 TTTTTTCCGG TCACTTTTTT TTCCCCCATT CTCTTCAATG TTTGGACATC AAATAGTTCA 840 AGAGCTGAGA GATGTCTGGC ACAGCTACCT AAGGGCCACA ACAAAATTCT GCTTGAACTA 900 GAGCCAGTAT TTGGAATCGA GAAGAATTTT TAAAAATATC TAATCTCCTC CTCTTAAGTG 960 CATGAAGCAT ATTCTGTGAC TATGTCTTGT ATGCACCAAA TTTATGTTCA CACATCTCAC 1020 TAGCCCTACA CTACGGATAT GGGCCACTGT ATTCTCTTTT TTGCTCATTA AATATGGACT 1080 CTGTGTGCAC TTATTCTCAA CCAGCACCAA ATGGTATAGC TCCAGGAGTA TTTGCCACCA 1140 ACAATAATGT GCATGCTGCT AGAAGCAAAT TGCGATTTCA GCAGCACCCA TAAACATTTA 1200 CCAGCACCTA CCATGTGCAG GCACTATACT CAGTTTTAGA GTTTCCAATA GATATGACAG 1260 ATATTGTTTT TAAAAGCTTT ACTATCTAGT TGTGGGAAAG AAGACTTACA AGTAAAAATG 1320 CAGGTAATGA TGTATGGCTA TGTATTAGTA CCAAATAAAT TCTATAAACA CTATGTACAA 1380 CTTTATATAT CACATCAAGT AAATTTATTC TACATCCTAT TAAGTAAACC ACAGATGGTC 1440 TCTGCCTTTC CATCCATTTA CCTCTCCTGG AAGCCACACC CTTATTTTCT GTTGAGGAAC 1500 TACTCCTGTC CTAGAATCTG GCAATCTGGT TTTAACAGCA GGGGCCCACG GATGGCATGT 1560 GAACAACCCT GGATTGAGTG ATGATGAATG ATTCAGAGGT GGACAGGAGC ATAATAATCA 1620 GTCTCAGAAA TTTTGCTAGG 1640
|